A new kind of cancer treatment works remarkably well for some patients but not others — and researchers want to … – Business Insider

A new kind of cancer treatment works remarkably well for some patients but not others — and researchers want to … – Business Insider

Business InsiderA new kind of cancer treatment works remarkably well for some patients but not others — and researchers want to …Business InsiderDan Chen, vice president and global head of cancer immunotherapy development at Genentech, told Business Insider that he considers Genentech’s checkpoint inhibitor, Tecentriq, to be the foundation of the company’s cancer immunotherapy program.and more »
A new kind of cancer treatment works remarkably well for some patients but not others — and researchers want to … – Business Insider